Investing
AbbVie·Cash Flow Statement·5 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Net cash from investing activities | -$1.1B | -$8.3B | -$1.9B | -$735M | -$1.2B | -$3.3B | -$1.5B | -$574M |
| Payments to Acquire Other Investments | $843M | $199M | $1.8B | $334M | $940M | $2.8B | $1.2B | $266M |
| Capital expenditures | $241M | $249M | $291M | $235M | $269M | $381M | $329M | $265M |
| Payment for (Proceeds from) Other Investing Activity | $5M | -$3M | -$197M | -$38M | -$11M | $77M | $1M | $43M |
| Acquisitions, net of cash acquired | — | $8.3B | — | $204M | — | — | — | $0 |